title: Evaluation of selected endocrine disorders after anticancer treatment of solid tumors in childhood.
authors.affiliation: Student's Science Society, Wroclaw Medical University, Poland.
authors.forename: Joanna
authors.initials: J
authors.lastname: Połubok
authors.affiliation: Student's Science Society, Wroclaw Medical University, Poland.
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Gonera
authors.affiliation: Student's Science Society, Wroclaw Medical University, Poland.
authors.forename: Olimpia
authors.initials: O
authors.lastname: Jasielska
authors.affiliation: Department of Paediatric Bone Marrow Transplantation, Oncology and Hematology.
authors.forename: Dorota
authors.initials: D
authors.lastname: Sęga-Pondel
authors.affiliation: Department of Paediatric Bone Marrow Transplantation, Oncology and Hematology.
authors.forename: Karolina
authors.initials: K
authors.lastname: Galant
authors.affiliation: Department of Paediatric Bone Marrow Transplantation, Oncology and Hematology.
authors.forename: Bernarda
authors.initials: B
authors.lastname: Kazanowska
authors.affiliation: Department of Basic Medical Science, Wroclaw Medical University, Poland.
authors.forename: Ewa
authors.initials: E
authors.lastname: Barg
mesh_terms: D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004700:Endocrine System Diseases / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents
keywords: BDM; IGF1; anticancer treatment; late effects; lipids